Skip to main content
PMC home page
Gut logoLink to Gut
. 1974 Jun;15(6):502–510. doi: 10.1136/gut.15.6.502

Progress report. Radioimmunoassay of intestinal hormones.

S R Bloom
PMCID: PMC1413005  PMID: 4604971

Full text

PDF
502

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSON J. C., BARTON M. A., GREGORY R. A., HARDY P. M., KENNER G. W., MACLEOD J. K., PRESTON J., SHEPPARD R. C., MORLEY J. S. SYNTHESIS OF GASTRIN. Nature. 1964 Dec 5;204:933–934. doi: 10.1038/204933a0. [DOI] [PubMed] [Google Scholar]
  2. Barbezat G. O., Grossman M. I. Intestinal secretion: stimulation by peptides. Science. 1971 Oct 22;174(4007):422–424. doi: 10.1126/science.174.4007.422. [DOI] [PubMed] [Google Scholar]
  3. Berson S. A., Yllow R. S. Nature of immunoreactive gastrin extracted from tissues of gastrointestinal tract. Gastroenterology. 1971 Feb;60(2):215–222. [PubMed] [Google Scholar]
  4. Bloom S. R. An enteroglucagon tumour. Gut. 1972 Jul;13(7):520–523. doi: 10.1136/gut.13.7.520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bloom S. R., Bryant M. G. Proceedings: The distribution of vasoactive intestinal peptide (VIP) in the primate gastrointestinal tract and characterization of VIP from human tumours. Gut. 1973 Oct;14(10):823–823. [PubMed] [Google Scholar]
  6. Bloom S. R., Polak J. M., Pearse A. G. Vasoactive intestinal peptide and watery-diarrhoea syndrome. Lancet. 1973 Jul 7;2(7819):14–16. doi: 10.1016/s0140-6736(73)91947-8. [DOI] [PubMed] [Google Scholar]
  7. Bloom S. R., Royston C. M., Thomson J. P. Enteroglucagon release in the dumping syndrome. Lancet. 1972 Oct 14;2(7781):789–791. doi: 10.1016/s0140-6736(72)92147-2. [DOI] [PubMed] [Google Scholar]
  8. Bloom S. R., Ward A. S. Proceedings: Secretin release in man after intra-duodenal acid. Gut. 1974 Apr;15(4):338–338. [PubMed] [Google Scholar]
  9. Bodanszky M., Klausner Y. S., Said S. I. Biological activities of synthetic peptides corresponding to fragments of and to the entire sequence of the vasoactive intestinal peptide. Proc Natl Acad Sci U S A. 1973 Feb;70(2):382–384. doi: 10.1073/pnas.70.2.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bodanszky M., Ondetti M. A., Levine S. D., Narayanan V. L., Von Saltza M., Sheehan J. T., Williams N. J., Sabo E. F. Synthesis of a heptacosapeptide amide with the hormonal activity of sccretin. Chem Ind. 1966 Oct 15;42:1757–1758. [PubMed] [Google Scholar]
  11. Boden G., Chey W. Y. Preparation and specificity of antiserum to synthetic secretin and its use in a radioimmunoassay (RIA). Endocrinology. 1973 Jun;92(6):1617–1624. doi: 10.1210/endo-92-6-1617. [DOI] [PubMed] [Google Scholar]
  12. Brown J. C., Cook M. A., Dryburgh J. R. Motilin, a gastric motor activity stimulating polypeptide: the complete amino acid sequence. Can J Biochem. 1973 May;51(5):533–537. doi: 10.1139/o73-066. [DOI] [PubMed] [Google Scholar]
  13. Brown J. C., Cook M. A., Dryburgh J. R. Motilin, a gastric motor activity-stimulating polypeptide: final purification, amino acid composition, and C-terminal residues. Gastroenterology. 1972 Mar;62(3):401–404. [PubMed] [Google Scholar]
  14. Brown J. C., Dryburgh J. R. A gastric inhibitory polypeptide. II. The complete amino acid sequence. Can J Biochem. 1971 Aug;49(8):867–872. doi: 10.1139/o71-122. [DOI] [PubMed] [Google Scholar]
  15. Brown J. C., Johnson L. P., Magee D. F. Effect of duodenal alkalinization of gastric motility. Gastroenterology. 1966 Mar;50(3):333–339. [PubMed] [Google Scholar]
  16. Brown J. C., Mutt V., Dryburgh J. R. The further purification of motilin, a gastric motor activity stimulating polypeptide from the mucosa of the small intestine of hogs. Can J Physiol Pharmacol. 1971 May;49(5):399–405. doi: 10.1139/y71-047. [DOI] [PubMed] [Google Scholar]
  17. Brown J. C., Mutt V., Pederson R. A. Further purification of a polypeptide demonstrating enterogastrone activity. J Physiol. 1970 Jul;209(1):57–64. doi: 10.1113/jphysiol.1970.sp009155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Brown J. C., Pederson R. A. A multiparameter study on the action of preparations containing cholecystokinin-pancreozymin. Scand J Gastroenterol. 1970;5(6):537–541. [PubMed] [Google Scholar]
  19. Brown J. C. Presence of a gastric motor-stimulating property in duodenal extracts. Gastroenterology. 1967 Feb;52(2):225–229. [PubMed] [Google Scholar]
  20. Chey W. Y., Hitanant S., Hendricks J., Lorber S. H. Effect of secretin and cholecystokinin on gastric emptying and gastric secretion in man. Gastroenterology. 1970 Jun;58(6):820–827. [PubMed] [Google Scholar]
  21. Dupre J., Ross S. A., Watson D., Brown J. C. Stimulation of insulin secretion by gastric inhibitory polypeptide in man. J Clin Endocrinol Metab. 1973 Nov;37(5):826–828. doi: 10.1210/jcem-37-5-826. [DOI] [PubMed] [Google Scholar]
  22. GREGORY H., HARDY P. M., JONES D. S., KENNER G. W., SHEPPARD R. C. THE ANTRAL HORMONE GASTRIN. STRUCTURE OF GASTRIN. Nature. 1964 Dec 5;204:931–933. doi: 10.1038/204931a0. [DOI] [PubMed] [Google Scholar]
  23. GREGORY R. A., TRACY H. J. THE CONSTITUTION AND PROPERTIES OF TWO GASTRINS EXTRACTED FROM HOG ANTRAL MUCOSA. Gut. 1964 Apr;5:103–114. [PMC free article] [PubMed] [Google Scholar]
  24. Gleeson M. H., Bloom S. R., Polak J. M., Henry K., Dowling R. H. Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function. Gut. 1971 Oct;12(10):773–782. doi: 10.1136/gut.12.10.773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Go V. L., Ryan R. J., Summerskill W. H. Radioimmunoassay of porcine cholecystokinin-pancreozymin. J Lab Clin Med. 1971 Apr;77(4):684–689. [PubMed] [Google Scholar]
  26. Gregory R. A., Tracy H. J. Isolation of two "big gastrins" from Zollinger-Ellison tumour tissue. Lancet. 1972 Oct 14;2(7781):797–799. doi: 10.1016/s0140-6736(72)92151-4. [DOI] [PubMed] [Google Scholar]
  27. HONG S. S., CHIN D. S., HUR K. B. Influences of hexamethonium and some dietary factors on human pancreatic and bile secretion. J Appl Physiol. 1961 Sep;16:810–814. doi: 10.1152/jappl.1961.16.5.810. [DOI] [PubMed] [Google Scholar]
  28. Harvey R. F., Dowsett L., Hartog M., Read A. E. A radioimmunoassay for cholecystokinin-pancreozymin. Lancet. 1973 Oct 13;2(7833):826–828. doi: 10.1016/s0140-6736(73)90863-5. [DOI] [PubMed] [Google Scholar]
  29. Holohan K. N., Murphy R. F., Flanagan R. W., Buchanan K. D., Elmore D. T. Enzymic iodination of the histidyl residue of secretin: a radioimmunoassay of the hormone. Biochim Biophys Acta. 1973 Sep 21;322(1):178–180. doi: 10.1016/0005-2795(73)90190-6. [DOI] [PubMed] [Google Scholar]
  30. Marks I. N., Bank S., Louw J. H. Islet cell tumor of the pancreas with reversible watery diarrhea and achylorhydraia. Gastroenterology. 1967 Apr;52(4):695–708. [PubMed] [Google Scholar]
  31. Meyer J. H., Way L. W., Grossman M. I. Pancreatic response to acidification of various lengths of proximal intestine in the dog. Am J Physiol. 1970 Oct;219(4):971–977. doi: 10.1152/ajplegacy.1970.219.4.971. [DOI] [PubMed] [Google Scholar]
  32. Pederson R. A., Brown J. C. Inhibition of histamine-, pentagastrin-, and insulin-stimulated canine gastric secretion by pure "gastric inhibitory polypeptide". Gastroenterology. 1972 Mar;62(3):393–400. [PubMed] [Google Scholar]
  33. Polak J. M., Bloom S., Coulling I., Pearse A. G. Immunofluorescent localization of enteroglucagon cells in the gastrointestinal tract of the dog. Gut. 1971 Apr;12(4):311–318. doi: 10.1136/gut.12.4.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Reeder D. D., Becker H. D., Smith N. J., Rayford P. L., Thompson J. C. Radioimmunoassay of cholecystokinin. Surg Forum. 1972;23(0):361–362. [PubMed] [Google Scholar]
  35. Rehefeld J. F. Three components of gastrin in human serum. Gel filtration studies on the molecular size of immunoreactive serum gastrin. Biochim Biophys Acta. 1972 Dec 28;285(2):364–372. [PubMed] [Google Scholar]
  36. Rubin B., Engel S. L., Drungis A. M., Dzelzkalns M., Grigas E. O., Waugh M. H., Yiacas E. Cholecystokinin-like activities in guinea pigs and in dogs of the C-terminal octapeptide (SQ 19,844) of cholecystokinin. J Pharm Sci. 1969 Aug;58(8):955–959. doi: 10.1002/jps.2600580810. [DOI] [PubMed] [Google Scholar]
  37. SAMOLS E., MARRI G., MARKS V. PROMOTION OF INSULIN SECRETION BY GLUCAGON. Lancet. 1965 Aug 28;2(7409):415–416. doi: 10.1016/s0140-6736(65)90761-0. [DOI] [PubMed] [Google Scholar]
  38. Said S. I., Mutt V. Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon. Eur J Biochem. 1972 Jul 13;28(2):199–204. doi: 10.1111/j.1432-1033.1972.tb01903.x. [DOI] [PubMed] [Google Scholar]
  39. Said S. I., Mutt V. Polypeptide with broad biological activity: isolation from small intestine. Science. 1970 Sep 18;169(3951):1217–1218. doi: 10.1126/science.169.3951.1217. [DOI] [PubMed] [Google Scholar]
  40. Said S. I., Mutt V. Potent peripheral and splanchnic vasodilator peptide from normal gut. Nature. 1970 Feb 28;225(5235):863–864. doi: 10.1038/225863a0. [DOI] [PubMed] [Google Scholar]
  41. Stern D. H., Walsh J. H. Gastrin release in postoperative ulcer patients: evidence for release of duodenal gastrin. Gastroenterology. 1973 Mar;64(3):363–369. [PubMed] [Google Scholar]
  42. Sum P. T., Preshaw R. M. Intraduodenal glucose infusion and pancreatic secretion in man. Lancet. 1967 Aug 12;2(7511):340–341. doi: 10.1016/s0140-6736(67)90176-6. [DOI] [PubMed] [Google Scholar]
  43. Thomson J. P., Bloom S. R., Haynes S., Ogawa O. Plasma enteroglucagon and plasma-volume changes after oral hypertonic glucose--their relationship to the dumping syndrome. Br J Surg. 1973 Apr;60(4):308–308. [PubMed] [Google Scholar]
  44. Unger R. H., Ohneda A., Valverde I., Eisentraut A. M., Exton J. Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose. J Clin Invest. 1968 Jan;47(1):48–65. doi: 10.1172/JCI105714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. VERNER J. V., MORRISON A. B. Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med. 1958 Sep;25(3):374–380. doi: 10.1016/0002-9343(58)90075-5. [DOI] [PubMed] [Google Scholar]
  46. Valverde I., Rigopoulou D., Exton J., Ohneda A., Eisentraut A., Unger R. H. Demonstration and characterization of a second fraction of glucagon-like immunoreactivity in jejunal extracts. Am J Med Sci. 1968 Jun;255:415–420. doi: 10.1097/00000441-196806000-00007. [DOI] [PubMed] [Google Scholar]
  47. WANG C. C., GROSSMAN M. I. Physiological determination of release of secretin and pancreozymin from intestine of dogs with transplanted pancreas. Am J Physiol. 1951 Feb;164(2):527–545. doi: 10.1152/ajplegacy.1951.164.2.527. [DOI] [PubMed] [Google Scholar]
  48. Walsh J. H., Grossman M. I. Circulating gastrin in peptic ulcer disease. Mt Sinai J Med. 1973 May-Jun;40(3):374–381. [PubMed] [Google Scholar]
  49. Wormsley K. G. Response to duodenal acidification in man. 3. Comparison with the effects of secretin and pancreozymin. Scand J Gastroenterol. 1970;5(5):353–360. [PubMed] [Google Scholar]
  50. Yalow R. S., Berson S. A. And now, "big, big" gastrin. Biochem Biophys Res Commun. 1972 Jul 25;48(2):391–395. doi: 10.1016/s0006-291x(72)80063-9. [DOI] [PubMed] [Google Scholar]
  51. Yalow R. S., Berson S. A. Further studies on the nature of immunoreactive gastrin in human plasma. Gastroenterology. 1971 Feb;60(2):203–214. [PubMed] [Google Scholar]
  52. Yalow R. S., Berson S. A. Size and charge distinctions between endogenous human plasma gastrin in peripheral blood and heptadecapeptide gastrins. Gastroenterology. 1970 May;58(5):609–615. [PubMed] [Google Scholar]
  53. Young J. D., Lazarus L., Chisholm D. J., Atkinson F. F. Radioimmunoassay of secretin in human serum. J Nucl Med. 1968 Dec;9(12):641–642. [PubMed] [Google Scholar]
  54. Young J. D., Lazarus L., Chisholm D. J. Radioimmunoassay of pancreozymin cholecystokinin in human serum. J Nucl Med. 1969 Dec;10(12):743–745. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES